Trial intelligence / Profile preview

Preemptive ibuprofen versus placebo for pain after temporary anchorage device placement

IRCT20210803052059N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pain comparing Ibuprofen with Placebo (2 arms). Primary endpoints: Severity and type of pain and Discomfort. Started Feb 2022; status: completed.

02

Drugs

ibuprofen
03

Conditions

pain

Beyond the preview

Go deeper on IRCT20210803052059N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210803052059N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call